$6.95
-0.25-3.47%
At close: -
$6.95
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Vir Biotechnology Earnings Estimates, EPS & Revenue | NASDAQ:VIR | Benzinga
Vir Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-0.880
Quarterly Revenue Estimate
$13.66M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$63.71M
Analyze the earnings history of Vir Biotechnology using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology | -$0.48 | -$0.88 | — | — | $56.38M | $13.66M | — | — | 05/01/2025 | Get Alert |
| VIR | Vir Biotechnology | -$0.86 | -$0.87 | -$0.76 | 12.64% | $16.79M | $8.14M | $12.37M | 52.01% | 02/26/2025 | Get Alert |
| VIR | Vir Biotechnology | -$1.22 | -$1.05 | -$1.56 | -48.57% | $2.64M | $5.51M | $2.38M | -56.81% | 10/31/2024 | Get Alert |
| VIR | Vir Biotechnology | -$1.45 | -$0.89 | -$1.02 | -14.61% | $3.80M | $7.50M | $3.08M | -59.00% | 08/01/2024 | Get Alert |
| VIR | Vir Biotechnology | -$1.06 | -$1.05 | -$0.48 | 54.29% | $62.96M | — | $56.38M | — | 05/02/2024 | Get Alert |
| VIR | Vir Biotechnology | -$0.76 | -$1.01 | -$0.86 | 14.85% | $49.41M | $12.15M | $16.79M | 38.16% | 02/22/2024 | Get Alert |
| VIR | Vir Biotechnology | $1.30 | -$1.21 | -$1.22 | -0.83% | $374.56M | $10.24M | $2.64M | -74.23% | 11/02/2023 | Get Alert |
| VIR | Vir Biotechnology | -$0.58 | -$1.20 | -$1.45 | -20.83% | -$40.63M | $25.89M | $3.80M | -85.33% | 08/03/2023 | Get Alert |
| VIR | Vir Biotechnology | $3.85 | -$0.87 | -$1.06 | -21.84% | $1.23B | $51.53M | $62.96M | 22.18% | 05/04/2023 | Get Alert |
| VIR | Vir Biotechnology | $3.92 | -$0.39 | -$0.76 | -94.87% | $812.75M | $97.30M | $49.41M | -49.22% | 02/23/2023 | Get Alert |
| VIR | Vir Biotechnology | $0.82 | — | $1.30 | — | $103.60M | — | $374.56M | — | 11/03/2022 | Get Alert |
| VIR | Vir Biotechnology | $0.46 | -$0.61 | -$0.58 | 4.92% | $177.07M | — | -$40.63M | — | 08/09/2022 | Get Alert |
| VIR | Vir Biotechnology | -$1.32 | $3.78 | $3.85 | 1.85% | $1.98M | $836.97M | $1.23B | 47.20% | 05/05/2022 | Get Alert |
| VIR | Vir Biotechnology | -$0.83 | $3.04 | $3.92 | 28.95% | $1.73M | $622.90M | $812.75M | 30.48% | 02/24/2022 | Get Alert |
| VIR | Vir Biotechnology | -$0.67 | $0.02 | $0.82 | 4000.00% | $1.93M | $138.25M | $103.60M | -25.06% | 11/04/2021 | Get Alert |
| VIR | Vir Biotechnology | -$0.27 | -$0.48 | $0.46 | 195.83% | $66.99M | $84.56M | $177.07M | 109.40% | 08/05/2021 | Get Alert |
| VIR | Vir Biotechnology | -$0.71 | -$0.21 | -$1.32 | -528.57% | $5.72M | — | $1.98M | — | 05/06/2021 | Get Alert |
| VIR | Vir Biotechnology | -$0.71 | -$0.70 | -$0.83 | -18.57% | $980.00K | $4.81M | $1.73M | -63.95% | 02/25/2021 | Get Alert |
| VIR | Vir Biotechnology | -$4.60 | -$0.60 | -$0.67 | -11.67% | $1.40M | — | $1.93M | — | 11/10/2020 | Get Alert |
| VIR | Vir Biotechnology | — | -$0.62 | -$0.27 | 56.45% | $2.05M | — | $66.99M | — | 08/11/2020 | Get Alert |
| VIR | Vir Biotechnology | -$3.19 | -$0.53 | -$0.71 | -33.96% | $3.66M | $2.92M | $5.72M | 95.82% | 05/12/2020 | Get Alert |
| VIR | Vir Biotechnology | -$3.05 | — | -$0.71 | — | — | — | $980.00K | — | 03/26/2020 | Get Alert |
Vir Biotechnology (VIR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $-0.76 | $-0.87 | 12.6 % |
| Q3 | 2024-10-31 | $-1.56 | $-1.05 | -48.6 % |
| Q2 | 2024-08-01 | $-1.02 | $-0.89 | -14.6 % |
| Q1 | 2024-05-02 | $-0.48 | $-1.05 | 54.3 % |
Vir Biotechnology (VIR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $12.37M | $8.14M | 52.0 % |
| Q3 | 2024-10-31 | $2.38M | $5.51M | -56.8 % |
| Q2 | 2024-08-01 | $3.08M | $7.50M | -59.0 % |
| Q4 | 2024-02-22 | $16.79M | $12.15M | 38.2 % |
FAQ
When is Vir Biotechnology (NASDAQ:VIR) reporting earnings?
Vir Biotechnology (VIR) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
What were the latest earnings per share (EPS) for Vir Biotechnology (NASDAQ:VIR)?
The Actual EPS was $-0.76, which beat the estimate of $-0.87.
What were Vir Biotechnology’s (NASDAQ:VIR) revenues?
The Actual Revenue was $12.4M, which beat the estimate of $8.1M.
Browse earnings estimates, EPS, and revenue on all stocks.